Biofeedback treatment for asthma

Chest

Volumn 126, Issue 2, 2004, Pages 352-361

  Lehrer, Paul M ^a   Vaschillo, Evgeny ^b   Vaschillo, Bronya ^b   Lu, Shou En ^c   Scardella, Anthony ^d   Siddique, Mahmood ^d   Habib, Robert H ^e  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e Mercy Children's Hospital   (United States)

Author keywords

Airway resistance; Alternative and complementary medicine; Disease severity; Heart rate variability; Oscillation mechanics; Psychology; Self regulation

Indexed keywords

FLUTICASONE; MONTELUKAST; PREDNISONE; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BREATHING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SELF ADMINISTRATION; ELECTROENCEPHALOGRAM; EXHALATION; EXPIRATORY FLOW; FEEDBACK SYSTEM; FEMALE; HEART RATE VARIABILITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PNEUMOGRAPHY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SELF EVALUATION; SPIROMETRY; SYMPTOM; TITRIMETRY; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 4143149631     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.2.352     Document Type: Article

References (35)

1. Wong CA, Walsh LJ, Smith CJ, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000; 355:1399-1403
2. Kelloway JS, Wyatt RA, Adlis S. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154:1349-1352
3. Singh V, Sinha HV, Gupta R. Barriers in the management of asthma and attitudes towards complementary medicine. Respir Med 2002; 96:835-840
4. Baldwin CM, Long K, Kroesen K, et al. A profile of military veterans in the southwestern United States who use complementary and alternative medicine: implications for integrated care. Arch Intern Med 2002; 162:1697-1704
5. Tsugeno H, Tsugeno H, Fujita T, et al. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis. Osteoporos Int 2002; 13:650-656
6. Matsumoto H, Ishihara K, Hasegawa T, et al. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients: a 4-year longitudinal study. Chest 2001; 120:1468-1473
7. Sivri A, Coplu L. Effect of the long-term use of inhaled corticosteroids on bone mineral density in asthmatic women. Respirology 2001; 6:131-134
8. Chan PW, DeBruyne JA. Parental concern towards the use of inhaled therapy in children with chronic asthma. Pediatr Int 2000; 42:547-551
9. Simon RA. Update on inhaled corticosteroids: safety, compliance, and new delivery systems. Allergy Asthma Proc 1999; 20:161-165
10. Hand CH, Bradley C. Health beliefs of adults with asthma: toward an understanding of the difference between symptomatic and preventive use of inhaler treatment. J Asthma 1996; 33:331-338
11. Lehrer PM, Carr RE, Smetankine A, et al. Comparison of respiratory sinus arrhythmia and neck/trapezius EMG biofeedback for asthma: a pilot study. Appl Psychophysiol Biofeedback 1997; 22:95-109
12. Lehrer P, Smetankin A, Potapova T. Respiratory sinus arrhythmia biofeedback therapy for asthma: a report of 20 unmedicated pediatric cases using the Smetankin method. Appl Psychophysiol Biofeedback 2000; 25:193-200
13. Kazuma N, Otsuka K, Matsuoka I, et al. Heart rate variability during 24 hours in asthmatic children. Chronobiol Int 1997; 14:597-606
14. European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use; Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93:1043-1065
15. Lehrer PM, Vaschillo E, Vaschillo B, et al. Heart rate variability biofeedback increases baroreflex gain and peak expiratory flow. Psychosom Med 2003; 65:796-805
16. Löfdahl CG, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ 1999; 319:87-90
17. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma; update on selected topics-2002. Washington, DC: US Department of Health and Human Services, 2002
18. Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback 2000; 25:177-191
19. Lehrer PM, Hochron SM, McCann B, et al. Relaxation decreases large-airway but not small-airway asthma. J Psychosom Res 1986; 30:13-25
20. Lehrer PM, Hochron S, Mayne T, et al. Relaxation and music therapies for asthma among patients prestabilized on asthma medication. J Behav Med 1994; 17:1-24
21. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 1995; 152:1107-1136
22. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659-664
23. Nagels J, Landser FJ, van der Linden L, et al. Mechanical properties of the lungs and chest wall during spontaneous breathing. J Appl Physiol 1980; 49:408-416
24. Habib RH, Jackson AC. Total respiratory system impedance with the upper airway wall shunt minimized. J Appl Physiol 1993; 74:1045-1055
25. Lutchen KR, Jackson AC. Reliability of parameter estimates from models applied to respiratory impedance data. J Appl Physiol 1987; 62:403-413
26. Lutchen KR, Habib RH, Dorkin HL, et al. Respiratory impedance and multibreath N2 washout in healthy, asthmatic, and cystic fibrosis subjects. J Appl Physiol 1990; 68:2139-2149
27. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972; 3:257-260
28. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974; 19:716-723
29. Rubin DB. Inference and missing data. Biometrika 1976; 63:581-592
30. van den Elshout FJ, van de Woestijne KP, Folgering HT. Variations of respiratory impedance with lung volume in bronchial hyperreactivity. Chest 1990; 98:358-364
31. Lee, ET. Statistical methods for survival data analysis. New York, NY: Wiley, 1992
32. Birrell MA, Crispino N, Hele DJ, et al. Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD. Br J Pharmacol 2002; 136:620-628
33. Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol 2001; 125:145-154
34. Lemanske RF Jr, Sorkness CA, Mauger EA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 2001; 285:2594-2603
35. Martin RM, Dunn NR, Freemantle SN, et al. Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists. Thorax 1998; 53:558-562